GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Compumedics Ltd (ASX:CMP) » Definitions » Institutional Ownership

Compumedics (ASX:CMP) Institutional Ownership : 1.25% (As of May. 17, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Compumedics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Compumedics's institutional ownership is 1.25%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Compumedics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Compumedics's Float Percentage Of Total Shares Outstanding is 0.00%.


Compumedics Institutional Ownership Historical Data

The historical data trend for Compumedics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compumedics Institutional Ownership Chart

Compumedics Historical Data

The historical data trend for Compumedics can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25

Compumedics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Compumedics (ASX:CMP) Business Description

Traded in Other Exchanges
N/A
Address
30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of Americas, Australia and the Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.

Compumedics (ASX:CMP) Headlines

From GuruFocus

Compass Minerals International Inc's Dividend Analysis

By GuruFocus Research 12-08-2023

Compass Minerals Declares Fiscal Second Quarter of 2023 Dividend

By Business Wire Business Wire 02-16-2023